Baker McKenzie Zurich has advised Yorkville Advisors Global, LP, a US-based investment firm offering debt and equity financing to global, small and micro-cap companies, on all legal aspects in connection with an up US$12 million convertible loan facility for SIX Swiss Exchange-listed Achiko AG (SIX: ACHI, ISIN CH0522213468).
The Convertible Facility Agreement provides for a committed tranche of US$2.5 million, which may be extended by up to US$9.5 million. Achiko AG plans to apply the funds raised under the Convertible Facility Agreement to fund the production of its Gumnuts test kits as well as Teman Sehat, its pandemic management ecosystem. Gumnuts is a novel cost-effective, non-invasive test for Covid-19 that Achiko licensed from Regenacellx.sl.
Baker McKenzie acted as counsel to Yorkville Advisors in this transaction. The Baker McKenzie team was led by Matthias Courvoisier (Partner, Capital Markets) and Philip Spoerlé (Senior Associate, Capital Markets and Banking & Finance) and further comprised Charlotte Rüegg (Associate, Banking & Finance) and Andrea Bolliger (Counsel, Tax).